FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

35150008: Glucocorticoid hormone (substance)

    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 01-Oct 2024. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    58652012 Glucocorticoid hormone en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    766757010 Glucocorticoid hormone (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    58652012 Glucocorticoid hormone en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    58652012 Glucocorticoid hormone en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    766757010 Glucocorticoid hormone (substance) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    766757010 Glucocorticoid hormone (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Glucocorticoid hormone Is a Corticosteroid and/or corticosteroid derivative false Inferred relationship Existential restriction modifier (core metadata concept)
    Glucocorticoid hormone Is a Adrenal cortex hormone false Inferred relationship Existential restriction modifier (core metadata concept)
    Glucocorticoid hormone Is a Steroid hormone false Inferred relationship Existential restriction modifier (core metadata concept)
    Glucocorticoid hormone Is a Glucocorticoid (substance) false Inferred relationship Existential restriction modifier (core metadata concept)
    Glucocorticoid hormone Has disposition Adrenal cortex hormone (disposition) false Inferred relationship Existential restriction modifier (core metadata concept)
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Flurandrenolide 4mcg/sq/cm tape The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Glucocorticoid hormone Inferred relationship Existential restriction modifier (core metadata concept)
    Flurandrenolide 4mcg tape The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Glucocorticoid hormone Inferred relationship Existential restriction modifier (core metadata concept)
    Fludroxycortide 500 microgram/mL cutaneous lotion The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Glucocorticoid hormone Inferred relationship Existential restriction modifier (core metadata concept)
    Dexamethasone acetate 8mg/mL injection solution vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Glucocorticoid hormone Inferred relationship Existential restriction modifier (core metadata concept)
    Methylprednisolone sodium succinate 40mg powder for injection solution vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Glucocorticoid hormone Inferred relationship Existential restriction modifier (core metadata concept)
    Methylprednisolone sodium succinate 125mg powder for injection solution vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Glucocorticoid hormone Inferred relationship Existential restriction modifier (core metadata concept)
    Methylprednisolone sodium succinate 1g powder for injection solution vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Glucocorticoid hormone Inferred relationship Existential restriction modifier (core metadata concept)
    Methylprednisolone sodium succinate 500mg powder for injection solution vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Glucocorticoid hormone Inferred relationship Existential restriction modifier (core metadata concept)
    Methylprednisolone sodium succinate 2g powder for injection solution vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Glucocorticoid hormone Inferred relationship Existential restriction modifier (core metadata concept)
    Betamethasone dipropionate 0.05% lotion The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Glucocorticoid hormone Inferred relationship Existential restriction modifier (core metadata concept)
    Betamethasone dipropionate 0.05% gel The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Glucocorticoid hormone Inferred relationship Existential restriction modifier (core metadata concept)
    Triamcinolone diacetate 25mg/mL injection suspension ampule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Glucocorticoid hormone Inferred relationship Existential restriction modifier (core metadata concept)
    Triamcinolone diacetate 40mg/mL injection suspension ampule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Glucocorticoid hormone Inferred relationship Existential restriction modifier (core metadata concept)
    Betamethasone dipropionate 0.5mg/g cream The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Glucocorticoid hormone Inferred relationship Existential restriction modifier (core metadata concept)
    Betamethasone dipropionate 0.5mg/g ointment The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Glucocorticoid hormone Inferred relationship Existential restriction modifier (core metadata concept)
    Dexamethasone acetate 16mg/mL injection solution vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Glucocorticoid hormone Inferred relationship Existential restriction modifier (core metadata concept)
    Betamethasone dipropionate 0.5mg cream The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Glucocorticoid hormone Inferred relationship Existential restriction modifier (core metadata concept)
    Betamethasone dipropionate0.5% ointment (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Glucocorticoid hormone Inferred relationship Existential restriction modifier (core metadata concept)
    Beclomethasone dipropionate 42mcg inhaler (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Glucocorticoid hormone Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram conventional release cutaneous lotion (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Glucocorticoid hormone Inferred relationship Existential restriction modifier (core metadata concept)
    Betamethasone (as betamethasone valerate) 1 mg/g cutaneous cream The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Glucocorticoid hormone Inferred relationship Existential restriction modifier (core metadata concept)
    Triamcinolone acetonide 0.055mg/inh The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Glucocorticoid hormone Inferred relationship Existential restriction modifier (core metadata concept)
    Triamcinolone acetonide 1 mg/g cutaneous ointment The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Glucocorticoid hormone Inferred relationship Existential restriction modifier (core metadata concept)
    Triamcinolone acetonide 0.05% The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Glucocorticoid hormone Inferred relationship Existential restriction modifier (core metadata concept)
    Triamcinolone acetonide 200mcg/spr The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Glucocorticoid hormone Inferred relationship Existential restriction modifier (core metadata concept)
    Triamcinolone acetonide 40mg/mL suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Glucocorticoid hormone Inferred relationship Existential restriction modifier (core metadata concept)
    Triamcinolone acetonide 250 microgram/mL cutaneous cream The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Glucocorticoid hormone Inferred relationship Existential restriction modifier (core metadata concept)
    Triamcinolone acetonide 40mg/mL injection (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Glucocorticoid hormone Inferred relationship Existential restriction modifier (core metadata concept)
    Triamcinolone acetonide 100mcg/spray The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Glucocorticoid hormone Inferred relationship Existential restriction modifier (core metadata concept)
    Triamcinolone acetonide 5 mg/mL cutaneous cream The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Glucocorticoid hormone Inferred relationship Existential restriction modifier (core metadata concept)
    Triamcinolone acetonide 3mg injection suspension ampule 1mL The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Glucocorticoid hormone Inferred relationship Existential restriction modifier (core metadata concept)
    Dexamethasone 4 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Glucocorticoid hormone Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely dexamethasone 750 microgram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Glucocorticoid hormone Inferred relationship Existential restriction modifier (core metadata concept)
    Dexamethasone 0.5mg/5mL elixir The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Glucocorticoid hormone Inferred relationship Existential restriction modifier (core metadata concept)
    Dexamethasone 1 mg/mL cutaneous solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Glucocorticoid hormone Inferred relationship Existential restriction modifier (core metadata concept)
    Dexamethasone sodium phospha 1mg/cc solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Glucocorticoid hormone Inferred relationship Existential restriction modifier (core metadata concept)
    Dexamethasone 10mg/25g The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Glucocorticoid hormone Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely dexamethasone 1 milligram/1 milliliter conventional release eye suspension (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Glucocorticoid hormone Inferred relationship Existential restriction modifier (core metadata concept)
    Dexamethasone sodium phosphate 1.0mg/mL ophthalmic solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Glucocorticoid hormone Inferred relationship Existential restriction modifier (core metadata concept)
    Prednisolone (as prednisolone sodium phosphate) 1 mg/mL oral solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Glucocorticoid hormone Inferred relationship Existential restriction modifier (core metadata concept)
    Prednisolone sodium phosphate 1% solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Glucocorticoid hormone Inferred relationship Existential restriction modifier (core metadata concept)
    Prednisolone sodium phosphat 5mg/5mL liquid (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Glucocorticoid hormone Inferred relationship Existential restriction modifier (core metadata concept)
    Prednisolone sodium phosphate 1/8% solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Glucocorticoid hormone Inferred relationship Existential restriction modifier (core metadata concept)
    Prednisolone sodium phosphat 6.7mg/5 mL solution (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Glucocorticoid hormone Inferred relationship Existential restriction modifier (core metadata concept)
    Fluocinonide 500 microgram/g cutaneous gel The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Glucocorticoid hormone Inferred relationship Existential restriction modifier (core metadata concept)
    Fluocinonide 500 microgram/mL cutaneous solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Glucocorticoid hormone Inferred relationship Existential restriction modifier (core metadata concept)
    Desonide 500 microgram/mL cutaneous cream The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Glucocorticoid hormone Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely desonide 500 microgram/1 milliliter conventional release cutaneous lotion (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Glucocorticoid hormone Inferred relationship Existential restriction modifier (core metadata concept)
    Desonide 500 microgram/g cutaneous ointment The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Glucocorticoid hormone Inferred relationship Existential restriction modifier (core metadata concept)
    Amcinonide 1 mg/g cutaneous ointment The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Glucocorticoid hormone Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely desoximetasone 500 microgram/1 milliliter conventional release cutaneous cream (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Glucocorticoid hormone Inferred relationship Existential restriction modifier (core metadata concept)
    Desoximetasone 500 microgram/g cutaneous gel The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Glucocorticoid hormone Inferred relationship Existential restriction modifier (core metadata concept)
    Desoximetasone 0.5% gel The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Glucocorticoid hormone Inferred relationship Existential restriction modifier (core metadata concept)
    Desoximetasone 2.5 mg/g cutaneous ointment The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Glucocorticoid hormone Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely desoximetasone 2.5 milligram/1 milliliter conventional release cutaneous cream (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Glucocorticoid hormone Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely betamethasone 600 microgram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Glucocorticoid hormone Inferred relationship Existential restriction modifier (core metadata concept)
    Beclomethasone dipropionate 40mcg aerosol The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Glucocorticoid hormone Inferred relationship Existential restriction modifier (core metadata concept)
    Beclomethasone dipropionate 80mcg aerosol The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Glucocorticoid hormone Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely fludroxycortide 500 microgram/1 milliliter conventional release cutaneous cream (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Glucocorticoid hormone Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely fludroxycortide 250 microgram/1 milliliter conventional release cutaneous cream (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Glucocorticoid hormone Inferred relationship Existential restriction modifier (core metadata concept)
    Fludroxycortide 500 microgram/g cutaneous ointment The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Glucocorticoid hormone Inferred relationship Existential restriction modifier (core metadata concept)
    Fludroxycortide 250 microgram/g cutaneous ointment The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Glucocorticoid hormone Inferred relationship Existential restriction modifier (core metadata concept)
    Triamcinolone 4 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Glucocorticoid hormone Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely triamcinolone 1 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Glucocorticoid hormone Inferred relationship Existential restriction modifier (core metadata concept)
    Prednisone 5 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Glucocorticoid hormone Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely prednisone 2.5 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Glucocorticoid hormone Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely prednisone 10 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Glucocorticoid hormone Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely prednisone 50 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Glucocorticoid hormone Inferred relationship Existential restriction modifier (core metadata concept)
    Betamethasone (as betamethasone dipropionate) 500 microgram/g cutaneous ointment The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Glucocorticoid hormone Inferred relationship Existential restriction modifier (core metadata concept)
    Betamethasone (as betamethasone dipropionate) 500 microgram/g cutaneous cream The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Glucocorticoid hormone Inferred relationship Existential restriction modifier (core metadata concept)
    Beclomethasone dipropionate 0.042% spray The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Glucocorticoid hormone Inferred relationship Existential restriction modifier (core metadata concept)
    Beclomethasone dipropionate 84mcg/spray spray The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Glucocorticoid hormone Inferred relationship Existential restriction modifier (core metadata concept)
    Beclometasone dipropionate 84 microgram/actuation nasal spray The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Glucocorticoid hormone Inferred relationship Existential restriction modifier (core metadata concept)
    Methylprednisolone sodium su 125mg injection The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Glucocorticoid hormone Inferred relationship Existential restriction modifier (core metadata concept)
    Triamcinolone acetonide 1 mg/mL cutaneous cream The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Glucocorticoid hormone Inferred relationship Existential restriction modifier (core metadata concept)
    Triamcinolone acetonide 50mcg spray The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Glucocorticoid hormone Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely halcinonide 1 milligram/1 milliliter conventional release cutaneous solution (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Glucocorticoid hormone Inferred relationship Existential restriction modifier (core metadata concept)
    Halcinonide 1 mg/g cutaneous ointment The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Glucocorticoid hormone Inferred relationship Existential restriction modifier (core metadata concept)
    Fluorometholone 0.1% ointment The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Glucocorticoid hormone Inferred relationship Existential restriction modifier (core metadata concept)
    Betamethasone 0.6mg/5mL syrup The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Glucocorticoid hormone Inferred relationship Existential restriction modifier (core metadata concept)
    Prednisolone (as prednisolone sodium phosphate) 3 mg/mL oral solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Glucocorticoid hormone Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely fluorometholone 2.5 milligram/1 milliliter conventional release eye suspension (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Glucocorticoid hormone Inferred relationship Existential restriction modifier (core metadata concept)
    Beclomethasone 84mcg (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Glucocorticoid hormone Inferred relationship Existential restriction modifier (core metadata concept)
    Beclomethasone dipropionate 8.4mg The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Glucocorticoid hormone Inferred relationship Existential restriction modifier (core metadata concept)
    Beclomethasone dipropionate 42mcg/spray The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Glucocorticoid hormone Inferred relationship Existential restriction modifier (core metadata concept)
    Methylprednisolone acetate 40mg/mL suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Glucocorticoid hormone Inferred relationship Existential restriction modifier (core metadata concept)
    Methylprednisolone acetate 40mg suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Glucocorticoid hormone Inferred relationship Existential restriction modifier (core metadata concept)
    Methylprednisolone acetate 80mg/mL suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Glucocorticoid hormone Inferred relationship Existential restriction modifier (core metadata concept)
    Dexamethasone sodium phospha 0.1% solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Glucocorticoid hormone Inferred relationship Existential restriction modifier (core metadata concept)
    Prednisolone acetate 25mg/mL The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Glucocorticoid hormone Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely prednisolone acetate 1.2 milligram/1 milliliter conventional release eye suspension (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Glucocorticoid hormone Inferred relationship Existential restriction modifier (core metadata concept)
    Prednisolone acetate 1.25 mg/mL eye suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Glucocorticoid hormone Inferred relationship Existential restriction modifier (core metadata concept)
    Prednisolone acetate 25mg/mL suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Glucocorticoid hormone Inferred relationship Existential restriction modifier (core metadata concept)
    Prednisolone acetate 50mg/mL The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Glucocorticoid hormone Inferred relationship Existential restriction modifier (core metadata concept)
    Clobetasol propionate 500 microgram/g cutaneous foam The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Glucocorticoid hormone Inferred relationship Existential restriction modifier (core metadata concept)
    Clobetasol propionate 500 microgram/g cutaneous gel The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Glucocorticoid hormone Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely clobetasol propionate 500 microgram/1 milliliter conventional release cutaneous solution (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Glucocorticoid hormone Inferred relationship Existential restriction modifier (core metadata concept)
    Betamethasone acetate + betamethasone sodium phosphate 3mg/3mg per mL injection suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Glucocorticoid hormone Inferred relationship Existential restriction modifier (core metadata concept)
    Betamethasone dipropionate + clotrimazole ns/10mg lotion (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Glucocorticoid hormone Inferred relationship Existential restriction modifier (core metadata concept)
    Dexamethasone + neomycin sulfate + polymyxin b sulfate 0.1%wv/ns/10000unt ointment (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Glucocorticoid hormone Inferred relationship Existential restriction modifier (core metadata concept)
    Dexamethasone + neomycin sulfate + polymyxin b sulphate 0.1%wv/ns/10000unt suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Glucocorticoid hormone Inferred relationship Existential restriction modifier (core metadata concept)

    Start Previous Page 4 of 5 End

    Reference Sets

    Concept inactivation indicator attribute value reference set (foundation metadata concept)

    POSSIBLY EQUIVALENT TO association reference set

    Back to Start